CORONA Remedies Limited (NSE:CORONA)
India · Delayed Price · Currency is INR 2,041.10
+2.80 (0.14%)
At close: Oct 7, 2026
CORONA Remedies Market Cap
CORONA Remedies has a market cap or net worth of 124.83 billion as of October 7, 2026.
Market Cap
124.83B
Enterprise Value
126.19B
Revenue
14.79B
Ranking
n/a
PE Ratio
62.62
Stock Price
2,041.10
ChartMarket Cap Chart
Since December 15, 2025, CORONA Remedies's market cap has increased from 87.97B to 124.83B, an increase of 41.90%. That is a compound annual growth rate of 53.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 124.83B | 47.38% |
| Dec 31, 2025 | 84.70B | -3.72% |
| Dec 15, 2025 | 87.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.33T |
| Divi's Laboratories | 2.44T |
| Lenskart Solutions | 1.20T |
| Apollo Hospitals Enterprise | 1.14T |
| Syngene International | 142.28B |
| Concord Biotech | 141.85B |
| Sudeep Pharma | 130.84B |
| Rainbow Children's Medicare | 125.91B |